Skip to main content
PMC home page
Journal of Anatomy logoLink to Journal of Anatomy
. 2000 May;196(Pt 4):609–616. doi: 10.1046/j.1469-7580.2000.19640609.x

Late-onset neurodegenerative diseases—the role of protein insolubility

WILLIAM G JOHNSON 1,✉
PMCID: PMC1468101  PMID: 10923991

Abstract

Recently, mutations of the alpha-synuclein gene were found to cause dominantly inherited Lewy-body Parkinson's disease (PD) and alpha-synuclein was identified as a major component of the Lewy body. However, the cause of the common form of PD, with a multifactorial rather than autosomal dominant inheritance pattern, remains unknown. Alpha-synuclein precipitates slowly and apparently spontaneously at high concentration in solution and the mutations that cause PD accelerate precipitation. Other dominantly inherited late-onset or adult-onset dominantly inherited neurodegenerative diseases are associated with precipitation of proteins. In Alzheimer disease, beta-amyloid and tau abnormalities are present and in prion disorders, prion proteins are found. In Huntington disease, a disorder with expanded CAG repeats, huntingtin precipitates occur. In dominantly inherited spinocerebellar ataxias, also expanded CAG repeat disorders, the corresponding ataxin protein precipitates are found. In multiple system atrophy, alpha-synuclein precipitates are encountered and in progressive supranuclear palsy, tau precipitates occur. In familial amyotrophic lateral sclerosis, a group of dominantly inherited disorders, SOD1 precipitates are found. Most of these disorders can involve the basal ganglia in some way.

Since similar processes seem to affect neurons of adults or older individuals and since a relatively limited group of proteins seems to be involved, each producing a form of neurodegeneration, it is possible that certain common features are present that affect this group of proteins. Candidates include a conformational shift, as in prions, an abnormality of the ubiquitin-proteosome pathway, as seen in PD, an abnormality of a pathway preventing precipitation (e.g. chaperonins), or potentiation of a pathway promoting precipitation (e.g. gamma-glutamyl-transpeptidase) or apoptosis. Elucidation of the pathways causing this protein insolubilisation is the first step towards approaching prevention and reversal in these late-onset neurodegenerative diseases.

Keywords: Neurodegeneration, insoluble protein precipitation

Full Text

The Full Text of this article is available as a PDF (133.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 1998 Nov;96(5):439–444. doi: 10.1007/s004010050917. [DOI] [PubMed] [Google Scholar]
  2. Blake C., Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure. 1996 Aug 15;4(8):989–998. doi: 10.1016/s0969-2126(96)00104-9. [DOI] [PubMed] [Google Scholar]
  3. Borden K. L. Structure/function in neuroprotection and apoptosis. Ann Neurol. 1998 Sep;44(3 Suppl 1):S65–S71. doi: 10.1002/ana.410440711. [DOI] [PubMed] [Google Scholar]
  4. Braak H., Sandmann-Keil D., Gai W., Braak E. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett. 1999 Apr 9;265(1):67–69. doi: 10.1016/s0304-3940(99)00208-6. [DOI] [PubMed] [Google Scholar]
  5. Conway K. A., Harper J. D., Lansbury P. T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998 Nov;4(11):1318–1320. doi: 10.1038/3311. [DOI] [PubMed] [Google Scholar]
  6. Crowther R. A., Jakes R., Spillantini M. G., Goedert M. Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett. 1998 Oct 9;436(3):309–312. doi: 10.1016/s0014-5793(98)01146-6. [DOI] [PubMed] [Google Scholar]
  7. Davidson W. S., Jonas A., Clayton D. F., George J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998 Apr 17;273(16):9443–9449. doi: 10.1074/jbc.273.16.9443. [DOI] [PubMed] [Google Scholar]
  8. Delacourte A., Buée L. Normal and pathological Tau proteins as factors for microtubule assembly. Int Rev Cytol. 1997;171:167–224. doi: 10.1016/s0074-7696(08)62588-7. [DOI] [PubMed] [Google Scholar]
  9. El-Agnaf O. M., Jakes R., Curran M. D., Middleton D., Ingenito R., Bianchi E., Pessi A., Neill D., Wallace A. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 1998 Nov 27;440(1-2):71–75. doi: 10.1016/s0014-5793(98)01418-5. [DOI] [PubMed] [Google Scholar]
  10. Engelender S., Kaminsky Z., Guo X., Sharp A. H., Amaravi R. K., Kleiderlein J. J., Margolis R. L., Troncoso J. C., Lanahan A. A., Worley P. F. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet. 1999 May;22(1):110–114. doi: 10.1038/8820. [DOI] [PubMed] [Google Scholar]
  11. Feany M. B., Dickson D. W. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol. 1996 Aug;40(2):139–148. doi: 10.1002/ana.410400204. [DOI] [PubMed] [Google Scholar]
  12. Feany M. B., Mattiace L. A., Dickson D. W. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol. 1996 Jan;55(1):53–67. doi: 10.1097/00005072-199601000-00006. [DOI] [PubMed] [Google Scholar]
  13. Gai W. P., Power J. H., Blumbergs P. C., Blessing W. W. Multiple-system atrophy: a new alpha-synuclein disease? Lancet. 1998 Aug 15;352(9127):547–548. doi: 10.1016/s0140-6736(05)79256-4. [DOI] [PubMed] [Google Scholar]
  14. Green D. R. Harm's way: polyglutamine repeats and the activation of an apoptotic pathway. Neuron. 1999 Mar;22(3):416–417. doi: 10.1016/s0896-6273(00)80695-9. [DOI] [PubMed] [Google Scholar]
  15. Hashimoto M., Hsu L. J., Sisk A., Xia Y., Takeda A., Sundsmo M., Masliah E. Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 1998 Jul 20;799(2):301–306. doi: 10.1016/s0006-8993(98)00514-9. [DOI] [PubMed] [Google Scholar]
  16. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998 Jun 18;393(6686):702–705. doi: 10.1038/31508. [DOI] [PubMed] [Google Scholar]
  17. Ishimaru H., Uéda K., Takahashi A., Maruyama Y. Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus. Brain Res. 1998 Mar 30;788(1-2):311–314. doi: 10.1016/s0006-8993(98)00033-x. [DOI] [PubMed] [Google Scholar]
  18. Jackson G. R., Salecker I., Dong X., Yao X., Arnheim N., Faber P. W., MacDonald M. E., Zipursky S. L. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 1998 Sep;21(3):633–642. doi: 10.1016/s0896-6273(00)80573-5. [DOI] [PubMed] [Google Scholar]
  19. Jackson G. S., Hosszu L. L., Power A., Hill A. F., Kenney J., Saibil H., Craven C. J., Waltho J. P., Clarke A. R., Collinge J. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science. 1999 Mar 19;283(5409):1935–1937. doi: 10.1126/science.283.5409.1935. [DOI] [PubMed] [Google Scholar]
  20. Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G., Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem. 1998 Oct 9;273(41):26292–26294. doi: 10.1074/jbc.273.41.26292. [DOI] [PubMed] [Google Scholar]
  21. Kelly J. W. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol. 1996 Feb;6(1):11–17. doi: 10.1016/s0959-440x(96)80089-3. [DOI] [PubMed] [Google Scholar]
  22. Kelly J. W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol. 1998 Feb;8(1):101–106. doi: 10.1016/s0959-440x(98)80016-x. [DOI] [PubMed] [Google Scholar]
  23. Kelly J. W. The environmental dependency of protein folding best explains prion and amyloid diseases. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):930–932. doi: 10.1073/pnas.95.3.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J. T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998 Feb;18(2):106–108. doi: 10.1038/ng0298-106. [DOI] [PubMed] [Google Scholar]
  25. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M. J., Jonnalagada S., Chernova T. The ubiquitin pathway in Parkinson's disease. Nature. 1998 Oct 1;395(6701):451–452. doi: 10.1038/26652. [DOI] [PubMed] [Google Scholar]
  26. Lippa C. F., Fujiwara H., Mann D. M., Giasson B., Baba M., Schmidt M. L., Nee L. E., O'Connell B., Pollen D. A., St George-Hyslop P. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol. 1998 Nov;153(5):1365–1370. doi: 10.1016/s0002-9440(10)65722-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Liu Y., Schubert D. Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity. J Neurochem. 1998 Dec;71(6):2322–2329. doi: 10.1046/j.1471-4159.1998.71062322.x. [DOI] [PubMed] [Google Scholar]
  28. Narhi L., Wood S. J., Steavenson S., Jiang Y., Wu G. M., Anafi D., Kaufman S. A., Martin F., Sitney K., Denis P. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem. 1999 Apr 2;274(14):9843–9846. doi: 10.1074/jbc.274.14.9843. [DOI] [PubMed] [Google Scholar]
  29. Ona V. O., Li M., Vonsattel J. P., Andrews L. J., Khan S. Q., Chung W. M., Frey A. S., Menon A. S., Li X. J., Stieg P. E. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature. 1999 May 20;399(6733):263–267. doi: 10.1038/20446. [DOI] [PubMed] [Google Scholar]
  30. Polymeropoulos M. H., Higgins J. J., Golbe L. I., Johnson W. G., Ide S. E., Di Iorio G., Sanges G., Stenroos E. S., Pho L. T., Schaffer A. A. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 1996 Nov 15;274(5290):1197–1199. doi: 10.1126/science.274.5290.1197. [DOI] [PubMed] [Google Scholar]
  31. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997 Jun 27;276(5321):2045–2047. doi: 10.1126/science.276.5321.2045. [DOI] [PubMed] [Google Scholar]
  32. Radford S. E., Dobson C. M. From computer simulations to human disease: emerging themes in protein folding. Cell. 1999 Apr 30;97(3):291–298. doi: 10.1016/s0092-8674(00)80739-4. [DOI] [PubMed] [Google Scholar]
  33. Saudou F., Finkbeiner S., Devys D., Greenberg M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998 Oct 2;95(1):55–66. doi: 10.1016/s0092-8674(00)81782-1. [DOI] [PubMed] [Google Scholar]
  34. Spillantini M. G., Crowther R. A., Jakes R., Cairns N. J., Lantos P. L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett. 1998 Jul 31;251(3):205–208. doi: 10.1016/s0304-3940(98)00504-7. [DOI] [PubMed] [Google Scholar]
  35. Sánchez I., Xu C. J., Juo P., Kakizaka A., Blenis J., Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron. 1999 Mar;22(3):623–633. doi: 10.1016/s0896-6273(00)80716-3. [DOI] [PubMed] [Google Scholar]
  36. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., Masliah E. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest. 1998 Sep;78(9):1169–1177. [PubMed] [Google Scholar]
  37. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol. 1998 Feb;152(2):367–372. [PMC free article] [PubMed] [Google Scholar]
  38. Tetrud J. W., Golbe L. I., Forno L. S., Farmer P. M. Autopsy-proven progressive supranuclear palsy in two siblings. Neurology. 1996 Apr;46(4):931–934. doi: 10.1212/wnl.46.4.931. [DOI] [PubMed] [Google Scholar]
  39. Tu P. H., Galvin J. E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J. Q., Lee V. M. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol. 1998 Sep;44(3):415–422. doi: 10.1002/ana.410440324. [DOI] [PubMed] [Google Scholar]
  40. Wakabayashi K., Hayashi S., Kakita A., Yamada M., Toyoshima Y., Yoshimoto M., Takahashi H. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 1998 Nov;96(5):445–452. doi: 10.1007/s004010050918. [DOI] [PubMed] [Google Scholar]
  41. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 1998 Jun 19;249(2-3):180–182. doi: 10.1016/s0304-3940(98)00407-8. [DOI] [PubMed] [Google Scholar]
  42. de Yébenes J. G., Sarasa J. L., Daniel S. E., Lees A. J. Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain. 1995 Oct;118(Pt 5):1095–1103. doi: 10.1093/brain/118.5.1095. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Anatomy are provided here courtesy of Anatomical Society of Great Britain and Ireland

RESOURCES